Substance Name: Anifrolumab [USAN:INN]
RN: 1326232-46-5
UNII: 38RL9AE51Q
Note
- In phase I clinical trials for treatment of systemic sclerosis; directed against type I IFN-alpha receptor.
Molecular Formula
- C6444-H9964-N1712-O2018-S44
Classification Code
- Treatment of Systemic Lupus Erythematosus (SLE)
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Anifrolumab [USAN:INN]
Synonyms
- Anifrolumab
- MEDI 546
- MEDI-546
- UNII-38RL9AE51Q
Registry Numbers
CAS Registry Number
- 1326232-46-5
FDA UNII
- 38RL9AE51Q
System Generated Number
- 1326232465